BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 16, 2018
View Archived Issues
Potential association of lonafarnib treatment with reduced mortality in children with HGPS
Read More
GAPVAC-101 trial of biomarker-guided actively personalized vaccines for glioblastoma completed
Read More
Phase II results presented for eculizumab in the treatment of Guillain-Barre syndrome
Read More
No improvement seen with LHA-510 in wet age-related macular degeneration trial
Read More
TapImmune and Marker Therapeutics agree to merger
Read More
PhoreMost receives new funding
Read More
Lilly gains AK-01 with AurKa Pharma acquisition
Read More
Shionogi patents new P2X7 antagonists
Read More
BioCryst Pharmaceuticals discloses kallikrein inhibitors
Read More
Tesaro identifies new CSF1R inhibitors
Read More
Roche discloses new TLR7 agonists for HBV infections
Read More
Medshine Discovery and collaborator present HGF receptor inhibitors
Read More
Novartis completes tender offer for outstanding shares of AveXis
Read More
Idorsia initiates registration study of lucerastat in adults with Fabry disease
Read More
Dimerix announces plans for phase II trials with DMX-200 in chronic kidney disease
Read More
CARB-X supports MicrobeDx's development of UTI diagnostic system
Read More
Aerie submits NDA to FDA for Roclatan
Read More
Inovio reports new data from phase I study of HIV vaccine Pennvax-GP
Read More
Otsuka highlights progress of first quarter 2018
Read More
FDA approves Truvada to reduce risk of HIV-1 infection in adolescents
Read More
V21-DOS47 immunoconjugate shows promising antitumoral activity in vivo
Read More
Pivotal study of Dupixent in moderate to severe atopic dermatitis in adolescents meets key endpoints
Read More
BioLamina and Novo Nordisk partner to develop novel stem cell-based therapies based on Biolaminins
Read More
Rexahn advances phase IIa study of RX-3117 and Abraxane in metastatic pancreatic cancer
Read More